Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Santen Pharmaceutical Co. Ltd (SNPHF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.21
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.8000 unch
on 01/07/19
15.1500 -2.31%
on 12/20/18
+0.1000 (+0.68%)
since 10/31/18
3-Month
14.7000 +0.68%
on 10/31/18
15.5200 -4.64%
on 10/12/18
-0.5900 (-3.83%)
since 09/18/18
52-Week
14.7000 +0.68%
on 10/31/18
18.1000 -18.23%
on 06/18/18
-0.4500 (-2.95%)
since 11/29/17

Most Recent Stories

More News
Santen to Conduct Activities to Raise Disease Awareness during World Glaucoma Week, March 10 to 16

Santen Pharmaceutical Co., Ltd. (hereinafter "Santen") announced on March 8 that as part of its initiatives to increase public awareness of glaucoma, it will sponsor activities to be conducted worldwide...

SNPHF : 14.8000 (-2.31%)
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update

TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, and through our license to Santen...

SNPHF : 14.8000 (-2.31%)
TCON : 1.44 (+2.13%)
Santen Hosts Event to Raise Public Awareness of Importance of Continued Glaucoma Treatment Prior to Sponsoring World Glaucoma Week in March

As part of its efforts to raise public awareness of glaucoma, Santen Pharmaceutical Co., Ltd. (hereinafter "Santen"), based in Osaka, will sponsor glaucoma awareness-raising activities to be conducted...

SNPHF : 14.8000 (-2.31%)
Trade SNPHF with:

Key Turning Points

2nd Resistance Point 14.8000
1st Resistance Point 14.8000
Last Price 14.8000
1st Support Level 14.8000
2nd Support Level 14.8000

See More

52-Week High 18.1000
Fibonacci 61.8% 16.8012
Fibonacci 50% 16.4000
Fibonacci 38.2% 15.9988
Last Price 14.8000
52-Week Low 14.7000

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar